Connection
John Somberg to Risk Assessment
This is a "connection" page, showing publications John Somberg has written about Risk Assessment.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.168 |
|
|
|
-
Somberg JC, McEwen P, Molnar J. Assessment of cardiovascular and noncardiovascular medical device recalls. Am J Cardiol. 2014 Jun 01; 113(11):1899-903.
Score: 0.511
-
Somberg JC. Risk assessment, drug approval, and liability. Am J Ther. 2006 May-Jun; 13(3):181-2.
Score: 0.296
-
Somberg JC. Guidelines for a new year. Am J Ther. 2014 Jan-Feb; 21(1):1.
Score: 0.126
-
Somberg JC. Flecainide: safety and efficacy. Cardiology. 2008; 111(2):82.
Score: 0.084
-
Nada A, Somberg J. First-in-Man (FIM) clinical trials post-TeGenero: a review of the impact of the TeGenero trial on the design, conduct, and ethics of FIM trials. Am J Ther. 2007 Nov-Dec; 14(6):594-604.
Score: 0.082
-
Somberg JC. The new drug evaluation process: risk benefit ratio. Am J Ther. 2005 May-Jun; 12(3):199-200.
Score: 0.069